Cargando…

Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration

The aim of our project was to perform an exploratory analysis of the cerebrospinal fluid (CSF) proteomic profiles of Multiple Sclerosis (MS) patients, collected in different phases of their clinical course, in order to investigate the existence of peculiar profiles characterizing the different MS ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liguori, Maria, Qualtieri, Antonio, Tortorella, Carla, Direnzo, Vita, Bagalà, Angelo, Mastrapasqua, Mariangela, Spadafora, Patrizia, Trojano, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123901/ https://www.ncbi.nlm.nih.gov/pubmed/25098164 http://dx.doi.org/10.1371/journal.pone.0103984

Ejemplares similares

Low Serum Urate Levels Are Associated to Female Gender in Multiple Sclerosis Patients
por: Zoccolella, Stefano, et al.
Publicado: (2012)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
por: Paolicelli, Damiano, et al.
Publicado: (2009)

Gender differences in safety issues during Fingolimod therapy: Evidence from a real‐life Relapsing Multiple Sclerosis cohort
por: Manni, Alessia, et al.
Publicado: (2017)

The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy
por: Paolicelli, Damiano, et al.
Publicado: (2016)

Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2022)

Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study
por: Iaffaldano, Pietro, et al.
Publicado: (2012)

Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis
por: Trojano, Maria, et al.
Publicado: (2012)

The Mitochondrial Dysfunction Hypothesis in Autism Spectrum Disorders: Current Status and Future Perspectives
por: Citrigno, Luigi, et al.
Publicado: (2020)

Neurodegeneration in multiple sclerosis
por: Mey, Gabrielle M., et al.
Publicado: (2022)

Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis
por: Gresle, Melissa M., et al.
Publicado: (2011)

Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis Pathogenesis
por: Nuzziello, Nicoletta, et al.
Publicado: (2018)

Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort
por: Manni, Alessia, et al.
Publicado: (2019)

Retinal and Brain Microglia in Multiple Sclerosis and Neurodegeneration
por: Choi, Soyoung, et al.
Publicado: (2021)

Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers
por: Novakova, Lenka, et al.
Publicado: (2018)

Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis
por: Huhn, Konstantin, et al.
Publicado: (2019)

Iron and Neurodegeneration in Multiple Sclerosis
por: Khalil, Michael, et al.
Publicado: (2011)

Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide
por: Bollo, Luca, et al.
Publicado: (2020)

Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
por: Correale, Jorge, et al.
Publicado: (2019)

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients
por: Simone, Isabella Laura, et al.
Publicado: (2006)

Mitochondrial dysfunction and neurodegeneration in multiple sclerosis
por: Su, Kimmy, et al.
Publicado: (2013)

Iron and neurodegeneration in the multiple sclerosis brain
por: Hametner, Simon, et al.
Publicado: (2013)

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2022)

Corneal axonal loss as an imaging biomarker of neurodegeneration in multiple sclerosis: a longitudinal study
por: Petropoulos, Ioannis N., et al.
Publicado: (2023)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

The Italian multiple sclerosis register
por: Trojano, Maria, et al.
Publicado: (2018)

Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches
por: Jafari, Ameneh, et al.
Publicado: (2021)

Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies
por: Simone, Isabella Laura, et al.
Publicado: (2021)

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
por: Campbell, Graham R, et al.
Publicado: (2011)

The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
por: Haider, Lukas, et al.
Publicado: (2016)

LIFESPAN NEURODEGENERATION OF THE HUMAN BRAIN IN MULTIPLE SCLEROSIS
por: Coupé, Pierrick, et al.
Publicado: (2023)

Lifespan neurodegeneration of the human brain in multiple sclerosis
por: Coupé, Pierrick, et al.
Publicado: (2023)

Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study
por: Liguori, Maria, et al.
Publicado: (2019)

Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms
por: Levin, Michael C, et al.
Publicado: (2014)

A Novel Homozygous Variant in DYSF Gene Is Associated with Autosomal Recessive Limb Girdle Muscular Dystrophy R2/2B
por: Spadafora, Patrizia, et al.
Publicado: (2022)

Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration
por: Quiroz-Baez, Ricardo, et al.
Publicado: (2020)

Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
por: Ayyadevara, Srinivas, et al.
Publicado: (2021)

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia
por: Ahmed, Rebekah M., et al.
Publicado: (2019)

Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important Players
por: Sandi, Dániel, et al.
Publicado: (2021)

Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity
por: Pisani, Francesco, et al.
Publicado: (2013)

Formation of amides: one-pot condensation of carboxylic acids and amines mediated by TiCl(4)
por: Leggio, Antonella, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t271sdob723mpk273cr9lq4ver